Mereo BioPharma MREO
NASDAQ MREO
$0.29 0.00 (-1.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Notes Payables (2017 - 2024)

Updated

Mereo BioPharma (MREO) reported Notes Payables of $5.54 million for Q4 2024, down 0.3% from the prior quarter.

Analysis

Mereo BioPharma (MREO) Notes Payables (2017 - 2024) Analysis & Trends

Dating back to Q4 2017, Mereo BioPharma's Notes Payables record includes 11 quarters.

  • Notes Payables has a five-year compound annual growth rate of -22.2% (FY2019 to FY2024).
  • By year, Notes Payables came in at $13.33 million in FY2022.
  • Five-year quarterly Notes Payables spans a low of $4.63 million in Q1 2024 and a high of $16.46 million in Q2 2020.
  • Per Business Quant data, the three quarters before Q4 2024 came in at $5.55 million (Q3 2024), $4.93 million (Q2 2024) and $4.63 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Mereo BioPharma 46.45 Mn -103.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5.54 Mn
Sep 30, 2024 5.55 Mn
Jun 30, 2024 4.93 Mn
Mar 31, 2024 4.63 Mn
Jun 30, 2023 5.28 Mn
Dec 31, 2022 13.36 Mn
Jun 30, 2020 16.32 Mn
Dec 31, 2019 19.85 Mn
Jun 30, 2019 10.16 Mn
Dec 31, 2018 8.68 Mn
Dec 31, 2017 2.61 Mn
API Access

Mereo BioPharma Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=MREO&period=max&api_key=YOUR_API_KEY